Information on major domestic and international academic papers applying TheraNovis core technologies
Cutting-edge research in spatial biology, cancer diagnostics, immunotherapy, biomedical imaging, and precision medicine.
A study investigating how the spatial distribution of immune cells and their proximity to STING-positive cells correlate with survival outcomes in glioblastoma.
A study characterizing lymphocyte-rich hepatocellular carcinoma and evaluating the prognostic significance of tertiary lymphoid structures in liver cancer.
This study used multiplexed immunohistochemistry to analyze immune profiles associated with recurrence after chemoradiation therapy in rectal cancer patients.
A study investigating how Crizotinib suppresses cancer metastasis through inhibition of TGFβ signaling pathways in non-small cell lung cancer cells.
A novel linker system designed to improve the therapeutic efficacy of HER2 antibody-drug conjugates for treatment-resistant HER2-positive cancers.
An investigation into how different tumor-infiltrating immune cell types influence immune checkpoint inhibitor treatment outcomes in advanced non-small cell lung cancer patients.
A study exploring CD69+CD103+ tissue-resident-like CD8+ T cells as a potential immunotherapeutic target for cholangiocarcinoma treatment.
A blood-based colorectal cancer diagnostic technology utilizing electrical detection of Colon Cancer Secreted Protein-2 for rapid and sensitive diagnosis.
A study on multiplexed in vivo imaging using size-controlled quantum dots operating in the second near-infrared window for enhanced biological imaging applications.
An MRI-based assessment of tumor vasculature heterogeneity during tumor progression and antiangiogenic therapy using permeability and blood volume parameters.
A study demonstrating how increased nicotinamide adenine dinucleotide levels promote colon cancer progression through suppression of reactive oxygen species.
A multiplexed colorectal cancer diagnostic platform using enzyme-sensitive ratiometric fluorescence dyes and antibody–quantum dot conjugates for highly sensitive detection.
